Abstract
Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points, as evidenced on fluorescein angiography, was largely used in the past, but now, it is almost completely abandoned, owing to the potential complications. Several studies confirmed the positive effects achieved by subthreshold laser treatment in CSC, even though its improper application in the PLACE trial has questioned the effectiveness.
Original language | English |
---|---|
Article number | 359 |
Pages (from-to) | 1-15 |
Number of pages | 15 |
Journal | Pharmaceuticals |
Volume | 13 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2020 |
Keywords
- Central serous chorioretinopathy
- Laser treatment
- Subthreshold laser
ASJC Scopus subject areas
- Molecular Medicine
- Pharmaceutical Science